Rhythm Pharmaceuticals Balance Sheet
NASDAQ: RYTMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Rhythm Pharmaceuticals financial position
At the end of fiscal 2025, Rhythm Pharmaceuticals reported total assets of $480.2 million, up 22.4% from a year earlier against total liabilities of $210.2 million. Shareholders' equity stood at $139.1 million, or 29.0% of assets. The company held $54.3 million in cash and equivalents against $108.2 million of debt, a net debt position of $53.9 million.
The current ratio (current assets divided by current liabilities) was 4.41, meaning short-term assets cover obligations due within a year. Debt-to-equity was 0.78.
Summary generated from market data by MetaCap's automated system. Methodology
Rhythm Pharmaceuticals balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 54.30M | 89.14M | 60.08M | 127.68M | 59.25M | 100.85M | 62.29M | 49.54M | 34.24M | 6.54M |
| Short-Term Investments | 334.65M | 231.43M | 215.76M | 205.61M | 235.61M | 71.94M | 230.16M | — | 113.85M | 4.00M |
| Receivables | 26.08M | 18.51M | 14.87M | 6.22M | 1.02M | — | — | — | — | — |
| Inventory | 25.75M | 18.74M | 8.62M | 2.92M | 111.00K | — | — | — | — | — |
| Total Current Assets | 466.92M | 374.20M | 308.27M | 354.24M | 308.39M | 181.67M | 302.40M | 258.69M | 150.67M | 11.18M |
| Property, Plant & Equipment | 1.10M | 632.00K | 1.34M | 2.20M | 2.81M | 3.19M | 3.67M | 1.12M | 840.00K | 930.00K |
| Intangible Assets | 5.32M | 6.17M | 7.03M | 7.88M | 4.66M | — | — | — | — | — |
| Total Assets | 480.20M | 392.27M | 332.75M | 382.48M | 329.52M | 187.07M | 308.52M | 260.21M | 151.74M | 12.34M |
| Accounts Payable | 13.95M | 12.33M | 4.88M | 4.80M | 5.74M | 4.90M | 10.41M | 7.64M | 2.43M | 1.90M |
| Short-Term Debt | 7.30M | 1.54M | — | — | — | — | — | — | — | — |
| Total Current Liabilities | 105.94M | 115.52M | 55.20M | 39.81M | 43.43M | 17.99M | 24.42M | 13.58M | 6.72M | 4.73M |
| Long-Term Debt | 100.89M | 108.27M | 106.14M | — | — | — | — | — | — | — |
| Total Liabilities | 210.17M | 227.72M | 162.99M | 118.22M | 45.37M | 20.55M | 27.50M | 13.95M | 6.95M | 5.04M |
| Shareholders' Equity | 139.07M | 21.73M | 169.76M | 264.26M | 284.15M | 166.53M | 281.02M | 246.26M | 144.79M | -32.70M |
| Retained Earnings | -1.35B | -1.16B | -894.74M | -710.06M | -528.94M | -459.33M | -325.33M | -184.60M | -110.25M | -76.54M |
| Total Debt | 108.18M | 109.81M | 106.14M | — | — | — | — | — | — | — |
| Net Cash (Debt) | 280.77M | 210.75M | 169.70M | 333.29M | 294.86M | 172.79M | 292.46M | 49.54M | 148.08M | 10.54M |
| Shares Outstanding | 67.21M | 62.39M | 59.43M | 56.61M | 50.28M | 44.24M | 44.00M | 34.41M | 27.28M | 10.20M |
This table shows 10 annual periods of Rhythm Pharmaceuticals's balance sheet, from FY 2025 back to FY 2016, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow RYTM's reporting calendar. What is a balance sheet?